+ All Categories
Home > Documents > Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

Date post: 13-Aug-2021
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
90
!"#$%&’ ) *’*&+, -./0) 1) 234 5167’* 89%)1 21$’"1: ;)"6&9-9<&+;= ;-&1&;) >? @"19 "#$%& ’()*+ ,(-./01*2 34(5$%)627 3#%89 :;<#9 =1$541>? @-1$2#& AB>9 34(526()62C$D *.#E F$6($EDG$D H(51>D$I& F3JK "#$% LM9 N9 LOOP
Transcript
Page 1: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!"#$%&'()(*'*&+,(-./0)(1)(234

5167'*(89%)1

21$'"1:(;)"6&9-9<&+;=(;-&1&;)(>?(@"19"#$%&!'()*+!,(-./01*2

34(5$%)627!3#%89!:;<#9!=1$541>?!@-1$2#&!AB>9

34(526()62C$D!*.#E!F$6($EDG$D!H(51>D$I&!F3JK"#$%!LM9!N9!LOOP

Page 2: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!"#$%&'()(*'*&+,(-./0)(1)(234

Q ;-)A&B&;)+'()"#$%&:

Q C=;-)6#(DEF(6&)<19A$&;#G(H)$9B#C&9-9<&'()"#$%&:((((

Q $)+,#)"#$%&'()(*'*&+,(-./0)R AIH")J'1$"&;I-="1:()"#$%&'

R ;9%9"9J.()"#$%&'

Q 0")6#)"#$%&'()(*'*&+,(-./0)

Q )1$&)"#$%&;)

Q %9K19A$&(&1J)C:J1:(-./0#()"#$%&:

Q A,"1I$:

Q &1B9"%)/1:(C6"9*'

Page 3: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

L"6'/1:(H7'J961:(A#A$.%

Page 4: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

E-)A&B&;)+'()"#$%&:

!"#$%&'(M(H9"I+,#(A"6'/1:,9("#$%IG(H9"I+,#($J9"0#()(J'6'1:('-';$"&+;N+,(JC"I+,O(R 0")6#)"#$%&'(PQ(RST%&1U(V($)+,#)"#$%&'(PWXSST%&1U

R 0'1&<1:(V(%)-&<1:(

R H)"9V#A%=-1:(V(H'"%)1'1$1:(V(&1+'AA)1$1:

R AIH")J'1$"&;I-="1:(V(;9%9"9J.R $)+,#;)"6&'(A'(Y$:,-N%(V(Y&"9;N%(Z[L(

Page 5: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

E-)A&B&;)+'(0")6#)"#$%&:

\9"I+,#(A&1IA9J.,9(IC-IR A&1IA9J=(0")6#;)"6&'R A&19(]()$"&=-1:(0-9;=6#

Q 2^(](22^(A$IH1_Q 222^(A$IH1_(](A&1IA9J=(C=A$)J)

R A&+;(A&1IA(A#16"9%(](A#16"9%(+,9".,9(A&1I

\9"I+,#()$"&9J'1$"&;I-="1:,9(IC-IR !`(0-9;=6)(2^(A$IH1_R !`(0-9;=6)(22^(L$IH1_

Q 8#H(2(](a'1+;'0)+,OJ(PAIH"),&A=-1:UQ 8#H(22(](b90&$COJ($#H(P&1B"),&A=-1:U

R !`(0-9;=6)(222^(A$IH1_(](;9%H-'$1:(0-9;

Page 6: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

E-)A&B&;)+'($)+,#)"#$%&:

8)+,#;)"6&'(A'(Y$:,-N%(Z[LR !`?[8

R 9"$96"9%1:(!`[8

R A:c9J.(B9;=-1:($)+,#;)"6&'

R A:c9J.(%);"9"''1$"#($)+,#;)"6&'R B&0"&-)+'(A:1:(

8)+,#;)"6&'(A'(Y&"9;N%(Z[LR ;9%9"9J=($)+,#;)"6&'

R )1$&6"9%1:(!`[8

R AIH")J'1$"&;I-="1:($)+,#;)"6&'(A()0'")+:

Page 7: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

d=;-)6#(DEF(6&)<19A$&;#

Page 8: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

d=;-)6#(DEF(6&)<19A$&;#

d=;-)61:((H7'J961:(&1$'"J)-#

Q 3,!MLO!R!LOO!H)

Q S,B!T!MOO!H)R ?#2$1C$D!MOO!R!MLO!H)

Q SU>!T!NNO!H)!VH.W1X

Q SU>!T!NYO!H)!VW($IX*%#(*>(!SU!50(!"2E(6627!!

Page 9: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

d=;-)6#(DEF(6&)<19A$&;#

e<^f( g(C=%_1)(AJ96O(P`hT`iU(

Page 10: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

d=;-)6#(DEF(6&)<19A$&;#

e<^f( g(B-I$$'"(A:1:(f(]()"$'B);$#(PH)";&1A91A;N($"'%9"U

Page 11: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

\)$9B#C&9-9<&'()"#$%&:(g(AI0A$"=$

\9"I+,#(J'6'1:(JC"I+,Ij!5(Z($(#2>(&!1)>?(H1(&!81/#[E2!-4(G%5$D?%!)I)6\H.R )1$%26#1+0$D!/0%*+5I&!26#1%G($6#1*.0+#$D!/0%*+5I&!/0%*+5I!G!#2H\$*%G\H!)I)6\H.

!019"%=-1:($J9"0)(JC"I+,Oj!(*6%-1>*\!8%*.)I&!2/$%#H+0$D!2.6%H2>1(&!)-%.]6^$+!2*61G162&!(_6#2*2#51+0$D!82*6%#IR (_6#2)I)6%0I&!!8%*+0$D!)D`%G\!C1!*%H%#%G\!2#I6H1(

!019"%=-1:(Y:7'1:(JC"I+,Oj!H2*#%a!C1!H1*#%#(($6#I!%*#.?I!a G#%E($\7!2*>())%#$D!)-%b*I&!cJd,U&!80.66(#!)D$Da ED)*2$\7!*%H%#%G\!62>?I*2#51(!-%!F:&!-%)611$>1)1%$+0$D!62>?I*2#51(!V-%!)#5(C$D>?!%-(#2>D>?X

a 81/#102>(!)D$D

Page 12: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

\)$9B#C&9-9<&'()"#$%&:(](%96I-I*:+:(B);$9"#

Q c.6%$%H$D!$(#G%Ge!)I)6\HQ J$164$D!-#%)64(5DR f&!d2&!:Z&!A2R c",R ?I-%_1(&!?I-(#*2-$1(&!1)>?(H1(!a!#(-(#8.E(

Q g$5%*#1$$D!)I)6\HR hI-%!_!?I-(#6I#([E2

Q i2#H2*2R -#%2#I6H1>*e!(8(*6!2$612#I6H1*R 1$6(#2*>(R 82#H2*%*1$(61*2&!82#H2*%5I$2H1*2&!51)6#1/.>(

Page 13: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

L#%H$9%#()"#$%&:

Q -20-162>(Q )$DW($+!6%0(#2$>(!$+H2?IQ 5.]$%)6Q )6($%*2#51(Q -#()I$*%-+0$D!)62GIQ )I$*%-2Q )#5(C$D!)(0?+$DQ $+?0+!)H#6

Page 14: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

LIH")J'1$"&;I-="1:()"#$%&'

\)"9V#A%=-1:(L`8(](k\L`8lR YOj!cJd,U

R kOj!cJ,U

R MOj!)D`%G+!62>?I*2#51(

L:c9J.(%);"9"''1$"#($)+,#;)"6&'R i0.66(#!)D$DQ UI-1>*e

Q c6I-1>*e

>&0"&-)+'(A:1:

Page 15: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!`?[8

M()$"&9J'1$"&;I-="1:(196=-1:("''1$"#($)+,#;)"6&'RS(g(mSn(H")J&6'-1N+,($)+,#;)"6&:(A'(Y$:,-N%(Z[L

b'+,)1&A%IAj(6I)-&$)(J'6'1:(J(90-)A$&(!`(*I1;+'G($#H&+;#(A-9o(](B)A$(PpSnU

DEFj(H")J^($)+,#;)"6&'(A'(Y$:,-N%(Z[LG("'$"9<"=61:(\(JT1'09($_A1_(C)(Z[L(PkHA'I69(Al(22G(222G()`>G((((HA'I69("(`X(UG(XiS(](hRST%&1

Page 16: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!`?[8

Page 17: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!`?[8(g(-./0)

Q !;I$1:(H7'"IY'1:()"#$%&'jR G2Z%G\!H2$\G#I

R J'")H)%&-(R(g(XS(%<(&^(J^

R %'$9H"9-9-(R(%<(&^J^!

R )6'19A&1(m(](Xq(%<(&^(J^

R V(0(*6#1>*+!*2#51%G(#E(X

Q e-9I,9690=(-./0)R V2$612#I6H1*27!A2a/0%*+6%#I&!/(62a/0%*+6%#I&!51Z%_1$&!-#%-28($%$X

R ;)$'$"9J=()0-)+'

Page 18: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

`)<9J.(%)1.J"#

a E-%H20($D!G(5($D!G!cJ!.E0.

Q J20)20GlG!H2$\G#Q 54(-Q 602*!$2!%C$D!/.0/IQ %HI6D!%/01C(b(!)6.5($%.!G%5%.Q H2)+W!*2#%61>*\?%!)1$.R GW5I!E2!H%$16%#2>(R -%.E(!$2!b(5$\!)6#2$^!E+#%G(`

Page 19: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

`)<9J.(%)1.J"#

Page 20: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!`[8M()$"&9J'1$"&;I-="1:("''1$"#($)+,#;)"6&'hS(](iSn(H")J&6'-1N+,($)+,#(A'(Y$:,-N%(Z[L

b'+,)1&A%IAj();+'AA9"1:(AH9*;#(P-'J9A$")11.G(H")J9A$")11.G()1$'"9T%&6TH9A$'"9A'H$=-1:UR AH9*;#(A;"#$.(](H9IC'("'$"9<"=61:(J'6'1:(→H9IC'(9"$96"9%1:($)+,#;)"6&'Q DEFj($)+,#(A'(Y$:,-N%(Z[LG("'$"9<"=61:(\(C)(Z[LG(([\(Q(\[

R AH9*;#(%)1&B'A$1:(](a\a(A#16"9%(](H"9T"'$"9<"=61:(J'6'1:Q DEFj(H"''V+&$)+'G(6'-$)(J-1)G()1$&6"9%1:(J'6'1:(]($)+,#(A'(Y&"9;N%(Z[L

Page 21: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!`[8

Page 22: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!`[8(g(-./0)

Q !;I$1:(H7'"IY'1:()"#$%&'jR G2Z%G\!H2$\G#I

R J'")H)%&-(R(g(XS(%<(&^(J^(R %'$9H"9-9-(R(%<(&^(J^R )6'19A&1(m(](Xq(%<(&^(J^(AcJg7!m3m!n!81/#102>(!)D$D!R!$(-%5+G26!25(H%)1$!2$1!b1$\!0\*I!E-%H20.bD>D!cJ!.E0%G\!G(5($D!R!#1E1*%!81/#102>(!*%H%#o!R!0\-(!$2-49!-#%-28($%$

R V(0(*6#1>*+!*2#51%G(#E(X

Q e-9I,9690=(-./0)R V2$612#I6H1*27!A2a/0%*+6%#I&!/(62a/0%*+6%#I&!-#%-28($%$&!)%620%0XR ;)$'$"9J=()0-)+'

Page 23: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

L:c9J=($)+,#;)"6&'(PB9;=-1:U

b'+,)1&A%IAj(8%*+0$D!0%W1)*%!(*6%-1>*\!2*61G16I!V)-.]6^$+!!2*61G162&!2/$%#H9!2.6%H261>162&!H1*#%#(($6#IX

r9;)-&C)+'j($(bC9!-%5\0!>#1)62!6(#H1$201)!V3BX&!5+0(!

)(-6.H&!)1$.)!$%520!#(($6#2$6!62>?I*2#51(&!$(25(*G+6$D!

)1$.)%G+!62>?I*2#51(

DEFj(MOO!a!LkOpH1$&!1E%(0(*6#1>*+!01$1(&!-%02#162!3!G0$I!R!

0%*201E2>(&!q2#Ha.-!R!>%%0a5%q$&!,3!r!3,

Page 24: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

L:c9J.($)+,#;)"6&'(g(-./0)

Q !;I$1:(H7'"IY'1:()"#$%&'jR J'")H)%&-(R(g(XS(%<(&^(J^(R %'$9H"9-9-(R(%<(&^(J^R H"9H)B'191(69(h(%<T;<(&^J^R )%&96)"91'(XRS(](iSS(%<(&^J^!.!-2>1($6l!)!5I)8.$*C$D!sfR V(0(*6#1>*+!*2#51%G(#E(X

Q e-9I,9690=(-./0)R 2$612#I6H1*27!A2a/0%*+6%#I&!/(62a/0%*+6%#I&!-#%-28($%$&!)%620%0&!2H1%52#%$(X

R ;)$'$"9J=()0-)+'

Page 25: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

L:c9J.(%);"9"''1$")1$1:($)+,#;)"6&'

Q 6I-1>*e!80.66(#!)D$D!R!t80.66(#!)D$D!F9!6I-.u!R E+G1)0e!$2!>2G%a6#1*.)-15+0$DH!1)6?H.

R >%.$6(#>0%>*q1)(!80.66(#!VPOj&!>%HH%$X&!>0%>*q1)(!80.66(#!V#(G(#)(!6I-1>20&!.$>%HH%$X

Q 26I-1>*e!V#2#(X!80.66(#R $(E+G1)0e!$2!>2G%a6#1*.)-15+0$DH!1)6?H.R >#1)62!6(#H1$201)&!(G($69!0(G%)D`%Ge!VH16#+0$D!2$.0.)&!-01>$D!WD0IX

Q Fc,U!R!1$>1E1%$+0$D!26#1+0$D!#(($6#I!62>?I*2#51(R b1EGI!-%!26#1%6%H11&!)62GI!-%!%-(#2>D>?!G#%E($e>?!)#59!G25

Page 26: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

8#H&+;N(B-I$$'"(A:1:

:(>?2$1)H.)7!H2*#%#(($6#I!62>?I*2#51(!G!3B&!*%0(H!6#1*.)-15+0$D?%!2$.0.&!5(81$%G2$e!2$26%H1>*e!%*#.?!V>#1)62!6(#H1$201)&!>2G%!R!6#1*.)-15+0$D!1)6?H.)X

gfv7!R AAm7!$(Z261G$D!V-10%G16\X!iw!FF&!FFF&!2Ji&!JY&!8#9!LxOakxO

R Am7!-%E161G$Dp$%6>?(5!iw!FF&!FFF&!2Ji&!JY&!8#9!LxOakxO

R cJ!*%$5.*>(!G^6]1$%.!LaN7M

Page 27: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

8#H&+;N(B-I$$'"(A:1:

Page 28: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!$#H&+;N(B-I$$'"(A:1:

:(>?2$1)H.)7!H2*#%#(($6#I!62>?I*2#51(!G!3B!$(/%!sB&!*%0(H!H16#+0$D?%!2$.0.&!-01>$D>?!W10&!*%0(H!b1E(G!-%!26#1%6%H11&!-%!*26(6#1E2C$D>?!2/02>D>?

gfv7!R 80.66(#%G\!G0$*I!#lE$e>?!H%#8%0%Z1D&!8#9!LxOakxO

R cJ!*%$5.*>(!G^6]1$%.!L!a!N7M

Page 29: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!$#H&+;N(B-I$$'"(A:1:

Page 30: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

>-I$$'"(A:1:(g(-./0)Q !;I$1:j

R 82#H2*%0%Z1>*+!*2#51%G(#E(7Q )%&96)"91'j(R]s(%<T;<(&^(J^(1)(iSgmS(%&1Q H"9H)B'191j(X^R]h(%<T;<(1)(XS]hS(%&1(1'09(mSS(%<(H^9^

R E-%H20($D!%5-%G^51!*%H%#7a 6&<9V&1(SGhR%<(=(h(,96G(69(XGR<a %'$9H"9-9-(hGRgR(%<(09-IA(=(i(%&1G(%)V^(iV(a J'")H)%&-(SGSsRgSGXR(%<T;<(1)(i(%&1a )%&96)"91'

R (0(*6#1>*+!*2#51%G(#E(!V5%!xO!=!/182E1>*IX

Q e-9I,9690=(-./0)R 2$612#I6H1*27!-#%-28($%$!n!/(62a/0%*+6%#&!)%620%0&!2H1%52#%$(R 2$61*%2Z.02>(R ;)$'$"9J=()0-)+'

Page 31: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

>&0"&-)+'(A:1:(P>LU

Q b(!).-#2G($6#1*.0+#$D!2#I6H1(&!>?2#2*6(#1E%G2$+!$(*%%#51$%G2$%.!)D`%G%.!2*61G16%.!)!$+)0(5$eH!E?%#]%G+$D!H(>?2$1>*\!8.$*>(!)D$D

Q $(bC2)6^b]D!-%#.>?2!)#5(C$D?%!#I6H.

Q -%)61W($D!?(H%5I$2H1*I!E?%#]($D!2!6#%H/(H/%01>*\!-4D?%5I!)1Z$181*2$6$^!EGI].bD!H%#62016.&!H%#/1516.!2!$+*025I!$2!-\C1!%!-2>1($6I!)!81/#102>D!)D$D

Page 32: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

>&0"&-)+'(A:1:

b'+,)1&A%IAj(H$%?%C(6$\!H1*#%#(($6#I!%*#.?I&!

)-%.]6^$I!2*61G16%.!(*6%-1>*e>?!8%*.)l!V-01>$D!

WD0IX&!#(H%5(02>(!)D$D

DEFj(81/#102C$D!G0$*I!(G($69!G0$^$D!1E%(09!01$1(&!t?#./%G0$$+!i1Bu&!t81/#%80.66(#u&!$(-#2G9!%5-%G^5!*%H%#!V.!$(0\C($e>?!MOOaMYOpH1$X

Page 33: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

>&0"&-)+'(A:1:

Page 34: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

DH&6'%&9-9<&'(>L

Q >>2!L9kOO9OOO!-6)!G!;Bc!2!N9xOO9OOO!-6)!G!g;!H+!81/#102>1!)D$D!

Q %5?25!-#(G20($>(!G!>(0*%G\!-%-.02>1!M!R!Yj!-#(G20($>(!$2#l)6+!)!G^*(H!Vk&y!j!r!YO!0(6&!!!!!!!P!j!r!yO!0(6&!yxj!-6)!r!Yx!0(6X

Q H.W1!M&M!j!G)!W($I!O&yj

Q %5?25%G2$e!$+#l)6!G!$+)0(5.bD>D>?!xO!0(6(>?!!!L&x!R!x_!

E![e25`!LE4rt[?u(D\2eDb2D!

Page 35: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

L$")$'<&'(-./0#(>L

Q E91$"9-)("#$%Ij(A#%H$9%)$&+;=(>L(PH)-H&$)+'G(,#H9$'1C'G(!\G(A"6^(A'-,=1:UR )1$&)"#$%&;)R ;)"6&9J'"C'R ;I")$&J1:(;)$'$"&C)/1:()0-)+'(

Q E91$"9-)(B"';J'1+'(](96H9J_6&(;9%9"R )1$&)"#$%&;)R H)-&)$&J1:(;)$'$"&C)/1:()0-)+'(!`?(v($"J)-=(;)"6&9A$&%I-)+'

Q !1$&;9)<I-)/1:($'")H&'

Page 36: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

>L(g(;91$"9-)("#$%I

Page 37: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

>L(g()1$&)"#$%&;)

Q )%&96)"91' XSS(g(wSS(%<T6'1R 8%6%)($E161G162&!-01>$D!6%_1>162&!-%0I$(.#%-261(&!6I#(%-261(&!5I)-(-)1(&!/#25I*2#51(&!!?(-26%6%_1>162&!#%?%G*%G+!5(-%E162

Q H"9H)B'191 wRS(](pSS(%<T6'1R *%H%#%G\!62>?I*2#51(&!)#5(C$D!)(0?+$D&!*%$G(#E(!$2!80.66(#!)D$D!)!#I>?0%.!%5-%G^5D!*%H%#

Q A9$)-9- XmS(](ihS(%<T6'1R 6%#)25()!5(!-%1$6()!V-#%50%.W($D!SUX&!)#5(C$D!)(0?+$D&!/#25I*2#51(&!(_2>(#/2>(!Ahz3d

Page 38: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

>L(g(;91$"9-)(B"';J'1+'

Q \$A(0'C(A"6'/1:,9(A'-,=1:R /(62a/0%*+6%#I!R 510612E(HR G(#2-2H10

Q \$A(A'(A"6'/1:%(A'-,=1:%R 51Z%_1$R 2H1%52#%$(

3:-9J=(B"';J'1+'j!YO!R!yOpH1$!G!*015.&!!!!!!!!!!PO!R!MMxpH1$!-41!)64(5$D!E+6^W1

Page 39: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

>L(g(;)"6&9J'"C'

Q xO!j!!-2#%_I)Hl!*%$CD!)-%$6+$$^!5%!LN!?%51$Q *2#51%G(#E(!5%!Ny!?%51$!%5!GE$1*.!-2#%_I)H.Q -41!5(0]DH!6#G+$D!b1W!$.6$+!2$61*%2Z.02C$D!-4D-#2G2!Vq2#82#1$1E2>(!H1$1H+0$^!k!R!N!6e5$I!-4(5!n!N!6e5$I!-%!*2#51%G(#E1X

Q (G($69!H%W$%!*2#51%G(#E1!-#%G\)6!1!/(E!2$61*%2Z.02C$D!-4D-#2GI&!-%*.5!b(!bD>$%G%.!(>?%*2#51%Z#281D!GI0%.C($2!1$6#2*2#51+0$D!6#%H/[E2

Q 2*.6$^!-41!?(H%5I$2H1>*\!5(6(#1%#2>1!o

Page 40: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

>L(g(B)"%);9-9<&+;=(;)"6&9J'"C'Q )%&96)"91'R xR{!HZp*Z!$2!kOaYO!H1$&!-%6\!M&LaM&y!Zp5($!5%!)26.#2>(!MO!Z&!-%6\!.5#W%G2>D!5+G*2!LOO!R!NOO!HZp5($

R d|7!?I-%6($E(&!/#25I*2#51(&!-#%50%.W($D!SU&!5I)-(-)1(&!80(/161)

Q H"9H)B'191R M9xRL!HZp*Z!$2!MORLO!H1$!$(/%!YOO!HZ!-9%9R d|7!?I-%6($E(&!5(/0%*%G2$e!80.66(#!)D$D

a CH9%)-'1:(96H9J_6&(;9%9"ja 51Z%_1$!O&LxHZ!+!L!?%5&!5%!M&xZa H(6%-#%0%0!L&xax!HZ!/%0.)!+!k!H1$&!H2_9!k_!a G(#2-2H10!O&O{xaO&Mx!HZp*Z!$2!k!H1$a 2H1%52#%$(

Page 41: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

>L(g('-';$"&+;=(;)"6&9J'"C'

Q *#+6*%5%/+!>(0*%G+!2$()6(E1(!V?I-$%H1526(&!-#%-%8%0X

Q Ge/%b!/18+E1>*e!V{O!R!M{O!=X!_! !!H%$%8+E1>*e!!!VLOO!R!kYO!=X

Q -#1H+#$D!})-^]$%)6!yx!R!Px!j

Q (G($69!-#(H(51*2>(!2$612#I6H1*I

Page 42: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

E9%9"9J.($)+,#;)"6&'

Q @'1&<1:R *%H%#%G\!(_6#2)I)6%0I!VfgBX&!$()(6#G20\!*%H%#%G\!62>?I*2#51(!VdBfUX!R!/(E!E$+H(*!%#Z2$1>*\?%!)#5(C$D?%!-%)61W($D!C1!-%#.>?!#(-%02#1E2>(

Q \9$'1+&=-1_(%)-&<1:R *%H-0(_$D!8%#HI!fgB&!dBfU!-41!%#Z2$1>*\H!-%)61W($D!)#5>(

Q b)-&<1:R !!81/#102>(!*%H%#&!80.66(#!*%H%#&!)(6#G20\!-%0IH%#8$D!C1!H%$%H%#8$D!fU

Page 43: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

E9%9"9J.($)+,#;)"6&'(IjQ 23xL

R #(($6#I&!2#I6H%Z($$DH!)./)6#+6(H!b1EG2!-%!F:&!51)-(#E(!#(8#2*6(#16!1)>?(H9!HI%*2#5.&!.!?(H%5I$9!6%0(#%G2$e>?!H%W$+!*26(6#%G+!2/02>(&!(G($69!1$51*2>(!*!FA<!V:c<FUX!

Q rZ8L(](89"A)6'(6'(\9&1$'AR G?%5$\!Z($(61>*\!GI](64($D&!-#1H9!_!)(*9!sSUB

Q 6&-)$9J)1.(;)"6&9%#9H)$&'R /.$50(!/#2$>?!#(($6#I!*%H%#%G+!62>?I*2#51(

Q J"9C'1N+,(A"6'/1:+,(J)6(J(69AH_-9A$&R -%)61$>1E1%$+0$D!#(($6#I!62>?I*2#51(!-%!%-(#2>D>?!JBJ&!#I>?0+!5(Z($(#2>(!5%!Ji&!*%#(*>(!?(H%5I$2H1*I

Q A$"I;$I"=-1_(19"%=-1:,9(A"6+'R 25($%E1$!)($E161G$D!fU!R!POj!,JzU!V8%*+0$DXR G(#2-2H10!)($E161G$D!fU!R!1$6#282)>1*.0+#$D!G!sf

Page 44: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

E9%9"9J.('V$")A#A$9-#

Page 45: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

E9%9"9J.('V$")A#A$9-#([T8

Page 46: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!;+'-'"9J)1N(&6&9J'1$"&;I-="1:("#$%IA

g("'H'"BIC1:()"#$%&'(I(!2b

Page 47: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

?'A'$"J)-=(E8

Page 48: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

L'$"J)-=(E8(P$J)"I(r@@@U

Page 49: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

>&0"&-)+'(;9%9"

Page 50: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

@'1&<1:(;9%9"9J.()"#$%&'(g(-./0)

a!;9%9"9J=('V$")A#A$9-&'G(?LE8R !;I$1:(-./0)j

Q 0'$)g0-9;=$9"(P1)H7^(%'$9H"9-9-(hGR(](R(%<(&^J^UG!.5#W%G2>D!5+G*2!-(#%#+0$^!50(!6%0(#2$>(

Q )%&96)"91'(XRS(](iSS(%<(&^J^Q *%#(*>(!G$164$D?%!-#%)64(5D!V)./)616.>(!f&!:Z&!*%#(*>(!2>15[EI&!?I-%_1(

Q 2$_1%0I61*2

R e-9I,9690=(-./0)Q 2$612#I6H1*2!V/(62a/0%*+6%#I&!(G($69!2H1%52#%$(XQ 2$_1%0I61*2Q ;)$'$"&C)/1:()0-)+'!

Page 51: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

b)-&<1:(;9%9"9J.()"#$%&'(g(-./0)

a!B&0"&-)+'TB-I$$'"(;9%9"G(A'$"J)-.(E8R !;I$1:(-./0)j

Q f3A,&!5(81/#102>(!Q )%&96)"91'(XRS(](iSS(%<(&^(J^(09-IA(PI6"K9J)+:(6=J;)(pSS(](XhSS(%<T6'1U

Q %'A9+)&1(XSS%<(&^(J^(09-IAQ %'$9H"9-9-(h(](i(%<(&^(J^(09-IAQ *%#(*>(!G$164$D?%!-#%)64(5D!V)./)616.>(!f&!:Z&!*%#(*>(!2>15[EI&!?I-%_1(

Q 0\C/2!(G($69!GIG%0+G2bD>D!-4DC1$I!VcF:&!-01>$D!(H/%01(&!3dz&!1$6%_1*2>(

R e-9I,9690=(-./0)Q 23e(P;)"6&9J'"$'"T6'B&0"&-=$9"UQ 2$612#I6H1*2!V2H1%52#%$(&!/(62a/0%*+6%#XQ ;)$'$"&C)/1:()0-)+'(

Page 52: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

LH'+&B&+;.($#H#(E8

89"A)6'A(6'(\9&1$'A

Page 53: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

LH'+&B&+;.($#H#(E8

89"A)6'A(6'(\9&1$'A(P86\U:(>?2$1)H.)7!-%#.>?2!#(-%02#1E2>(!*%H%#&!50%.?e!SU!1$6(#G20

BI$5#%H!50%.?\?%!SU!1$6(#G20.!VsSUBXa G#%E($e!R!Z($(61>*+!-%#.>?2!1%$6%Ge>?!*2$+0la ED)*2$e!R!)%620%0&!(#I6#%HI>1$&!6(#8($251$&!*(6%*%$2E%0&!2H1%52#%$(~

!;I$1:(-./0)(86\ja b<L5w()K(h(<(&^(J^a 1)%-#($201$!*(!EGe]($D!Ui!Vx!.ZpH1$Xa $.>($+!5%C2)$+!*2#51%)61H.02>(!*(!EGe]($D!Ui

Page 54: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

rZ8L

Page 55: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!"#$%&+;=(09I7'

a!#(>151G.bD>D!1$>())2$6$D!H201Z$D!*%H%#%G\!2#I6H1(a!G^6]1$%.!.!-2>1($6l!)(!)6#.*6.#+0$DH!%$(H%>$^$DH!)#5>(&!5I)8.$*C$D!sf

a -#%G+E($\!%-2*%G2$eH1!Ge/%b1!FA<r./0)ja 19!G9!2H1%52#%$(!POO!R!MLOO!HZp5($a *%#(*>(!G$164$D?%!-#%)64(5Da (G($69!#(-#%Z#2H2>(!FA<!a 2$_1%0I61*2&!)(52>(&!(G($69!>(0*%G+!2$()6(E1(a $.>($+!*2#51%)61H.02>(!*(!EGe]($D!Ui

Page 56: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

@")6#;)"6&'

Page 57: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

L&1IA9J=(C=A$)J)

Page 58: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!`(0-9;=6#

Q !`(0-9;=6)(2^(A$IH1_7!-#%50%.W($D!G(5($D&!-#%50%.W($D!3,!1$6(#G20.!$25!LOO!H)!!

Q !`(0-9;=6)(22^(A$IH1_R 2^($#HI!R!m($>*(/2>?7!-%)6.-$\!-#%50.W%G+$D!1$6(#G20.!2W!*!GI-25$.6D!cJ!-4(G%5.&!).-#2?1)+0$D!R!H\$^!-#%Z$%)61>*I!E+G2W$+

R 22^($#HI!R!:%/16E7!1$8#2?1)+0$D&!-%)61W($D!51)6+0$D?%!-4(G%5$D?%!)I)6\H.&!-#%Z$%)61>*I!E+G2W$+

Q !`(0-9;=6)(222^(A$IH1_7!*%H-0(6$D!cJ!/0%*+52&!$+?#25$D!b.$*C$D!$(/%!*%H%#%Ge!#I6H.)!

Page 59: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!`(0-9;=6)(2^(A$IH1_

Page 60: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!`(0-9;=6)(22^(A$IH1_(g(a'1+;'0)+,!!

Page 61: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!`(0-9;=6)(222^(A$IH1_

Page 62: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

yI1;/1:("#$%IA

Page 63: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

r@@@

Page 64: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

[@@@

Page 65: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

@")6#)"#$%&'(g(-./0)Q 90'+1_j

R $(-%5+G26!/#25I*2#51E.bD>D!0\*IR *%#(*>(!G$164$D?%!-#%)64(5D!V?I-(#*20\H1(X!n!?I-%6(#H1(&!?I-%6I#([E2~

Q );I$1_jR )$"9H&1(SGR(%<((&^(J^G()K(69(hGR(%<(&^(J^(R &A9H"'1)-&1(&1&+&=-1_(R(I<T%&1(P6=-'(6-'(96H9J_6&(;9%9"UR ;)"6&9A$&%I-)+'

Q E(G$D!V6#2$)6%#2*+0$D!R!5(81/#10+6%#IXQ 6#2$)G($[E$D!5%C2)$+!*2#51%)61H.02>(7!*2$I02>(!AJf&!G12!G9!)./>02G12!$(/%!b.Z.02#1)!V0\-(!G0(G%X&!E2G(5($D!(0(*6#%5I!5%!3f!V*%$6#%02!50(!H%$16%#.!(G($69!)*12)*%-1>*IX&!}-#2G2!-%0%?I!50(!-2#2H(6#l!)61H.02>(!V)61H.02C$D!-#+?&!)($)1$ZX&!$2)62G($D!E2b1]�%G2>D!8#(*G($>(&!G^6]1$%.!H%5(!JJF

Q 6-9I,9690_jR 6#G20+!*2#51%)61H.02>(

Page 66: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

\bT23eQ b(5$%5.61$%G\!_!5G%.5.61$%G\!_!/1G($6#1*.0+#$D

Q )61H.02>(!*%H%#!V)D$DX!50(!$2-#%Z#2H%G2$\!8#(*G($>(!R!)($)1$Z!G02)6$D!(0(*6#1>*\!2*61G16I

Q FA<7!2$6162>?I*2#51>*e!-2>1$Z!VcU3X&!FA<!)?%>*!Vn!)61H.02>(X

Q H2Z$(6!n!3:!⇒!G^6]1$%.!81_$D!)61H.02>(!MOOpH1$

Q H2Z$(6!n!FA<!⇒!GI-$.6D!6(#2-1(!VGe/%blX

Page 67: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

L:c9J=(;)"6&9A$&%I-)+'

Page 68: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

E9%9"9J=(;)"6&9A$&%I-)+'

Page 69: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

L';J'1/1:(;)"6&9A$&%I-)+'(A:1:()(;9%9"

Page 70: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!1$&)"#$%&;)

`)I<,1(](a&--&)%A(;-)A&B&;)+'jF9 /0%*+6%#I!)%5D*%G\?%!*2$+0.R Fc!-#%50.W.bD!#(-%02#1E2>17!�.1$151$

R F"!E*#2>.bD!#(-%02#1E2>17!H()%>21$

R FA!$(%G01G`.bD!#(-%02#1E2>17!-#%-28($%$

R /(62!R!/0%*+6%#I

R -#%50%.W($D!#(-%02#1E2>(7!2H1%52#%$(&!)%620%0

R *20>1%G\!/0%*+6%#I!

Page 71: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

\"9H)B'191

Q ?(H%5I$2H1*27R $(Z261G$^!1$%6#%-$D&!0(?*\!)$DW($D!BUf

Q 1$6(#2*>(7R EGI].b(!(8(*6!51Z%_1$.!2!q2#82#1$.&!H(62/%01E2>(!-4()!>I6%>?#%H(!3!NxO!L<Y

Q $(W+5%.>D!}C1$*I7R $2.E(2&!*%G%G+!-2>?.�&!2)6?H2&!E+>-2

Q -#%2#I6H1(7!R -%0IH%#8$D!fU&!81/#102>(!*%H%#

Page 72: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

L9$)-9-

Q ?(H%5I$2H1*27R )10$e!/(62a/0%*.bD>D!(8(*6&!/#25I*2#51(

Q 1$6(#2*>(7R -%6($>12>(!}C1$*.!51Z%_1$.&!G(#2-2H10.

Q $(W+5%.>D!}C1$*I7R -%5%/$\!/(62a/0%*+6%#lH&!}$2G2

Q -#%2#I6H1(7!R 6%#)25()!5(!-%1$6()

Page 73: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!%&96)"91'

Q ?(H%5I$2H1*27R ?I-%6($E(&!$(H^$D!gi!sf

Q 1$6(#2*>(7R EGI].b(!*%$>($6#2>1!51Z%_1$.&!q2#82#1$.&!>I*0%)-%#1$.&!/(62a/0%*.bD>D!1!A2a/0%*.bD>D!(8(*6

Q $(W+5%.>D!}C1$*I7R ?(-26%a&!-.0H%6%_1>162&!?I-%a!1!?I-(#6I#([E2&!8%6%)($E161G162&!*%#$(+0$D!5(-%E162

Q -#%2#I6H1(7!R 6%#)25()!5(!-%1$6()&!81/#102>(!*%H%#!

Page 74: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

!6'19A&1'

Q ?(H%5I$2H1*27R -l)%/D!!M!R!x!)(>&!)1$.)9!62>?I*2#51(&!G2E%510262>(

Q 1$6(#2*>(7R EGe]($e!(8(*6!.!-2>1($6l!.WDG2bD>D>?!51-I#152H%0&!)$DW($e!.!6(%8I01$l

Q $(W+5%.>D!}C1$*I7R -4(>?%5$^!/%0()61!$2!?#.51&!5.]$%)6

Q -#%2#I6H1(7!R 81/#102>(!)D$D&!)1$.)%G+!E+)62G2

Page 75: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

21J)C:J1:(-./0)($)+,#)"#$%&:

Page 76: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

E)$'$"&C)/1:()0-)+'(!`?[8

g([>()0-)+'(H9%)-.(6"=,#(J(90-)A$&(E9+,9J)($"9*z,'-1:;I(J(H")J.(A:1&

R )1)$9%&+;N(H7:A$IHR '-';$"9)1)$9%&+;N(H7:A$IH((((((((((((((⇒(;9%0&1)+'(909I(

DB';$j((ppnG("';I"'1+'(Q(inE9%H-&;)+'j(SGR(n(!`(0-9;=6)G(&%H-)1$)+'(\b

Page 77: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

E)$'$"&C)/1:()0-)+'(!`[8

a H2-%G+$D!26#1+0$D!$(/%!G($6#1*.0+#$D!1$E(#>(!)-%b*I!*%0(H!H16#+0$D?%!$(/%!6#1*.)-15+0$D?%!2$.0.&!)(-62

r'J9A$")11.(AH9*;#!R!-4D)6.-!#(6#%Z#+5$D!V29!8(H%#201)!R!2%#62X!$(/%!6#2$))(-6+0$D!VG9!8(H%#201)!R!sBXa (8(*67!W(pRnG!#(*.#($>(!Q(Rna *%H-01*2>(7!T!Mj!62H-%$+52&!M!a!Lj!)I)6\H%G+!(H/%01E2>(

\")J9A$")11.(AH9*;#!R!)62$59!-#2G%)6#2$$e!-4D)6.-a (8(*67!qqnG!#(*.#($>(!hXna *%H-01*2>(7!H1$1H9!

L'H$=-1:(AH9*;#!R!0(G%)6#2$$e!$(/%!-#2G%)6#2$$e!-4D)6.-a (8(*67!∼(pSna *%H-01*2>(7!#1E1*%!cJ!/0%*+5I!.!-2#2?1)+0$D>?!)-%b(*

Page 78: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

E)$'$"&C)/1:()0-)+'(B9;=-1:(A:c9J.($)+,#;)"6&'

a %)H9J=1:(1'*/)A1_*Y:(A:c9J.();$&J&$#(9H"9$&(C)/=$;I(\(J-1#(1)(H9J"+,9J.%(DEF(((((((((((PiS(](XSS(%AU

a J#IK&$:(ie(%)H9J)+:+,(A#A$.%O

DB';$j(qmnG("';I"'1+'(qn

E9%H-&;)+'j(%&1&%^(

Page 79: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

E)$'$"&C)/1:()0-)+'($#H&+;.,9(B-I$$'"I(A:1:

a J#$J97'1:(-&1'="1:(-.C'(1)(&A$,%I(%'C&($"&;IAH&6=-1:(+,-9H1:()(J'1)(+)J)(&1B'"&9"

a +:-j(69A)K'1:(0&6&"';+&91=-1:,9(0-9;I(1)(38(&A$,%I

g8(*67!qR(g(pRn&!#(*.#($>(!Q(XSn

f%H-01*2>(7!H1$1H9

Page 80: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

E)$'$"&C)/1:()0-)+'(B&0"&-)+'(A:1:

X^ H)-&)$&J1:(]()0-)+'(!`(*I1;+'(v(&%H-)1$)+'(8ELQ A$=-'(&16&;9J=1)(I(H$A(A(&1+'AA)1$1:("#+,-9I(96H^(;9%9"G(

B)"%);9"'C&A$'1$1:G("&C&;9($)+,#;)"6&+;.(Eb\{(

h^ ;I")$&J1:R '-&%&1)+'($"&<<'"O(](&C9-)+'(H-&+1:+,(K&-

Q ;91J'1/1:(H7:A$IHG([8FG(r!LL5(;)$'$"#

R %96&B&;)+'(AI0A$"=$I(](-&1'="1:(-.C'Q ie('-';$"9)1)$9%&+;.(%)H9J)+:(A#A$.%#(P3![85G([\bG(((((((

D?gL28DG(?!`|U

v(+,&"I"<&+;=(-./0)(](b!dDG(&16&;9J=1)(I(JY'+,(H$A(A(>&L(H96A$IHI*:+:+,(;)"6&9+,&"I<&+;N(JN;91({

Page 81: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

E)$'$"&C)/1:()0-)+'(B&0"&-)+'(A:1:

216&;)+'j(J#A9+'(A#%H$9%)$&/$:(H$AG(B)"%);9"'C&A$'1$1:(PX(g(h(!!UG(H"'B'"'1/1_(H)"9V#A%=-1:TH'"C&A$'1$1:(>&L(A(1'6&-)$9J)19I((rL(PQ(wR(%%U

DB';$j(W(qRn

E9%H-&;)+'j(A$'1}C)(H-&+1:+,(K&-(PQ(hnUG($)%H91=6)G(H'"B9")+'(*:+1I

Q 1I$19A$($")1AA'H$=-1:(HI1;+'Q 1I$19A$()1$&;9)<I-)/1:(H7:H")J#

Page 82: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

E)$'$"&C)/1:()0-)+'(B&0"&-)+'(A:1:

Page 83: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

L,"1I$:

Page 84: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

8)+,#;)"6&'(A'(Y$:,-N%(Z[L(PQ(XhS(%AU

Q -#2*61>*I!GW5I!).-#2G($6#1*.0+#$D

Q <<7!H2)+W!*2#%61>*\?%!)1$.&!25($%)1$!!!!V⇒E-%H20($D!%5-%G^51!*%H%#&!5(H2)*%G+$D!3!G0$X!

Q G2Z%G\!H2$\G#I

Q 25($%)1$!Y!R!My!HZ!19!G9

Q G(#2-2H10!x!R!MO!HZ!19!G9

Q ?(H%5I$2H1>*+!1$)62/10162!⇒!(0(*6#1>*+!*2#51%G(#E(

Page 85: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

8)+,#;)"6&'(A'(Y&"9;N%(Z[L(PW(XhS(%AU

Q -%*.5!$($D!b2)$+!5Z9!R!0\C16!b2*%!*%H%#%G%.!62>?I*2#511

Q <<R *%H%#%G+!62>?I*2#51(R ).-#2G($6#1*.0+#$D!62>?I*2#51(!)!2/(#2>D!V/0%*(H!#2H\$*2R 2$615#%H$D!cJ,U!R!G(5($D!-4()!-4D526$%.!)-%b*.

Q AcJg!G(#2-2H10Q 2H1%52#%$(!MxO!R!kOO!HZ!19!G9Q -41!?(H%5I$2H1>*\!1$)62/1016^!-#%H-6$D!(0(*6#1>*+!*2#51%G(#E(

Page 86: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

ee($)+,#;)"6&:(A'(Y&"9;N%(Z[L

f g(a\a(v(B&0"&-)+'(A:1:

Page 87: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

ee($)+,#;)"6&:(A'(Y&"9;N%(Z[L

Q )6#.*6.#+0$D!%$(H%>$^$D!)#5>(!�!Pxj!fU

Q %)2!S,B!R!PO!2W!R!MyO!�!fU

Q H%#8%0%Z1(!,"""!r!MNO!H)!�!MOOj!fU

Q H%#8%0%Z1(!s"""!r!MYO!H)!�!MOOj!fU

Q H%#8%0%Z1(!6I-1>*+!-#%!s"""!$(/%!,"""!R!)-D](!BJU!)!2/(#2>D

Q ,B!r!MOO!H)!�!fU

Q $(Z261G$D!*%$*%#52$>(!S,B!�!fU

Page 88: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

21B9"%)/1:(C6"9*'

Q v.15(01$()!'()*\!*2#51%0%Z1>*\!)-%0(C$%)61R qqq9*2#51%a>E9>E

Q v.15(01$()!gG#%-)*\!*2#51%0%Z1>*\!)-%0(C$%)61R qqq9()>2#51%9%#Z

Q "#2.$q205w)!h(2#6!<1)(2)(!y6?!(5161%$!B2.$5(#)!LOOy

Q c)>?(#H2$$7!f2#51%0%Z1(&!v20\$!LOON

Q qqq96%#)25()9%#Z

Q qqq9�65#.Z)9%#Z

Q qqq95#.Za1$6(#2>61%$)9>%H

Page 89: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

((\")+9J&Y$_(&1J)C:J1:()(&1$'"J'1/1:((('-';$"9B#C&9-9<&'(2EE(>?(@"19(E)"6&9A$&%I-)/1:(A$7'6&A;9

J(5%.>D!0\*247!<%>9!:;<#9!:102$!f%E+*&!3?<s\*2417!:;<#9!,lW($2!s+/#%G+!3?<&!:;<#9!=16*2!J02]D$%G+&!3?<&!!!!!!!!!!!!!:;<#9!s./%HD#!f41G2$!3?<&!:;<#9!U%H+]!d%G%6$e!3?<&!:;<#9!:102$!B(-]1&!:;<#9!z$54(b!U%H2$&!<%>9!:;<#9!:2#61$!i1202!3?<

B62$1C$D!)()6#27!=2$2!d%G+C*%G+

E91$);$jb4e"^(5167'*(89%)1( 916"'*^$9%)1~)$-)A^+CcH/.02$>(7!RihhihpwXf%#%$+#$D!b(5$%6*27!RihhihmRXg0(*6#%8IE1%0%Z1>*e!)+0(*7!RihhihXms!

fBpc#I6H%!2H/.02$>(7!R(ihhi(ippig0(*6#%8IE1%0%Z1>*e!)+0(*7!R(ihhi(hXmsFH-02$62C$D!)+0(*7!R(ihhi(hXiX

Page 90: Beta - blokátory v terapii ICHS - AKUTNE.CZ · d=;-)6#(def(6&)

! !

e_;I*&(C)(H9C9"19A$^


Recommended